Published in:
01-03-2021 | NSCLC | Case report
Olmutinib/osimertinib
Development of acquired resistance: 20 case reports
Published in: Reactions Weekly | Issue 1/2021
Login to get accessExcerpt
Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event